Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Operating costs and expenses
Research and development	$ 927,696	$ 388,934	$ 1,574,924	$ 523,684
Research and development - licenses acquired (including stock-based compensation)	354,683	10,000	394,515	20,000
Compensation and related expenses (including stock-based compensation)	391,699	133,486	557,396	454,935
Professional fees (including stock-based compensation)	750,029	544,849	1,556,063	838,364
Rent	2,591	8,234	11,008	15,263
Other expenses	89,119	182,083	238,361	244,705
Total operating expenses	2,515,817	1,267,586	4,332,267	2,096,951
Loss from operations	(2,515,817)	(1,267,586)	(4,332,267)	(2,096,951)
Other expenses
Other expense, net	18,287		8,161
Total other expenses	18,287		8,161
Net loss	$ (2,497,530)	$ (1,267,586)	$ (4,324,106)	$ (2,096,951)
Weighted average number of common shares outstanding, basic and diluted	12,304,263	9,603,134	11,277,665	8,312,327
Net loss per share, basic and diluted	$ (0.2)	$ (0.13)	$ (0.38)	$ (0.25)
Net loss	$ (2,497,530)	$ (1,267,586)	$ (4,324,106)	$ (2,096,951)
Other comprehensive loss
Foreign currency translation adjustment	(662)		(662)
Total comprehensive loss	$ (2,498,192)	$ (1,267,586)	$ (4,324,768)	$ (2,096,951)